How have BTX shares performed in 2024?

Brooklyn ImmunoTherapeutics' stock was trading at $4.1020 at the beginning of the year. Since then, BTX stock has decreased by 47.6% and is now trading at $2.15. View the best growth stocks for 2024 here .

How do I buy shares of Brooklyn ImmunoTherapeutics?

Shares of BTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:BTX

Brooklyn ImmunoTherapeutics (BTX) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free BTX Stock Alerts

$2.15

-0.01 (-0.46%)

(As of 04/17/2024 ET)

Compare

Today's Range: $2.07
▼
$2.37
50-Day Range: $1.55
▼
$4.10
52-Week Range: $0.17
▼
$10.10

Volume: 2,666 shs
Average Volume: 515,543 shs
Market Capitalization: $126.48 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Headlines Social Media

Get Brooklyn ImmunoTherapeutics alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Brooklyn ImmunoTherapeutics Stock (NYSE:BTX)

Eterna Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.

BTX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BTX Stock News Headlines

April 12, 2024 | americanbankingnews.com

Brooklyn ImmunoTherapeutics (NYSE:BTX) Earns Hold Rating from Analysts at StockNews.com

December 19, 2023 | abcnews.go.com

'Brooklyn Nine-Nine' star Andre Braugher dies at 61

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

December 2, 2023 | nypost.com

Sabrina Carpenter blows off Catholic Church scandal: ‘Jesus was a carpenter’

December 2, 2023 | travel.usnews.com

Brooklyn Bridge

November 8, 2023 | time.com

Brooklyn Bedding Coupon for November

September 28, 2023 | nypost.com

Dozens of vendors still swarm Brooklyn Bridge in free-for-all — selling illegal cocktails, pics with live snake: photos

August 29, 2023 | mirror.co.uk

Brooklyn Beckham's wife Nicola Peltz 'to be grilled on camera' over bitter wedding spat

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

June 29, 2023 | health.usnews.com

Brooklyn Hospital Center

June 22, 2023 | ft.com

Pure joy: the best of Brooklyn’s cool natural wine scene

June 8, 2023 | forbes.com

Best Moving Companies In Brooklyn, New York June 2023

May 7, 2023 | usnews.com

Brooklyn Technical High School

May 6, 2023 | usnews.com

Brooklyn Preparatory High School

March 31, 2023 | dailymail.co.uk

Brooklyn Beckham: Latest news, views, gossip, photos and video

March 18, 2023 | mirror.co.uk

Billionaire heiress Nicola Peltz and Brooklyn Beckham saving to buy their 'dream house'

March 11, 2023 | mirror.co.uk

Victoria Beckham 'fears for son Brooklyn and his wife Nicola' amid wedding lawsuit

March 1, 2023 | nytimes.com

In Brooklyn, a Tiny Apartment and a Neighborhood Filled With Families

March 1, 2023 | nypost.com

Brooklyn’s priciest rental of 2023 has quickly found a tenant

February 26, 2023 | cbsnews.com

Police ask for help identifying driver at the scene of shooting, carjacking in Brooklyn Park

February 23, 2023 | foxnews.com

Brooklyn Nets sign head coach Jacque Vaughn to multiyear contract extension

February 19, 2023 | nytimes.com

For Strictly Observant Jews in Brooklyn, the Sabbath Expands

February 5, 2023 | yahoo.com

7 Times Brooklyn Beckham Got Roasted for His Questionable Cooking Skills

January 30, 2023 | dailymail.co.uk

Cruz Beckham teaches brother Brooklyn how to cook as he whips up a pizza on family outing in Miami

January 28, 2023 | nypost.com

Like Brooklyn Beckham, I’m a ‘one of the girls’ husband — and I love it

November 12, 2022 | mirror.co.uk

Victoria Beckham ignores Brooklyn and Nicola's anniversary posts as she teases book club

November 4, 2022 | finance.yahoo.com

Brooklyn ImmunoTherapeutics Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Quarterly Report on Form 10-Q

See More Headlines

Receive BTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brooklyn ImmunoTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Information
Industry: Television Broadcasting
Sub-Industry: N/A
Current Symbol: NYSE:BTX
CUSIP: N/A
CIK: N/A
Web: N/A
Phone: (212) 582-1199
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 58,826,000
Free Float: N/A
Market Cap: $126.48 million
Optionable: No Data
Beta: 4.61

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Matthew Angel
President, Chief Executive Officer & Director
Andrew C. Jackson
Chief Financial Officer
Roger Sidhu
Chief Medical Officer
Jay Sial
Chief Administrative Officer
Sandra Gurrola
Principal Accounting Officer & VP-Finance

Key Competitors

View All Competitors

BTX Stock Analysis - Frequently Asked Questions

How have BTX shares performed in 2024?: Brooklyn ImmunoTherapeutics' stock was trading at $4.1020 at the beginning of the year. Since then, BTX stock has decreased by 47.6% and is now trading at $2.15.
View the best growth stocks for 2024 here.
How do I buy shares of Brooklyn ImmunoTherapeutics?: Shares of BTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BTX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Brooklyn ImmunoTherapeutics (BTX) Stock Price, News & Analysis

About Brooklyn ImmunoTherapeutics Stock (NYSE:BTX)

BTX Stock Price History

BTX Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

BTX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info